Immunome Q4 Adj EPS $(0.15) Beats $(0.28) Estimate, Sales $3.83M Beat $2.07M Estimate

IMMUNOME, INC. +1.91%

IMMUNOME, INC.

IMNM

16.00

+1.91%

Immunome (NASDAQ: IMNM) reported quarterly losses of $(0.15) per share which beat the analyst consensus estimate of $(0.28) by 46.43 percent. This is a 76.56 percent increase over losses of $(0.64) per share from the same period last year. The company reported quarterly sales of $3.83 million which beat the analyst consensus estimate of $2.07 million by 84.83 percent.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via